Is A Recovery Imminent In Haemonetics Stock After Falling 40% This Year?
- Thursday, September 23, 2021, 7:55
- Market
- Add a comment
We believe that Haemonetics stock, best known for its blood and plasma supplies and services, is a good buying opportunity at the present time. HAE stock trades near $70 currently and it is, in fact, down 42% from its pre-Covid high of $122 in February 2020 – just before the coronavirus pandemic…
About the Author
admin123 has written 23527 stories on this site.
